Project Grant R01DA061185
Award Date
7/1/25
Completion Date
3/31/30
Dollars Obligated
$716K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award of $1,383,618 from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 - Drug Use and Addiction Research Programs supports research to investigate the microglia-mediated adverse effects of cannabis (specifically Delta-9-tetrahydrocannabinol or THC) on prefrontal cortex maturation and cognitive function during adolescence. The research aims to: 1) identify the time course of cannabinoid receptor type 1 (CNR1)-mediated molecular and morphological...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $169,580 Project Grant to the University of Maryland, Baltimore to investigate the effects of Delta-9-Tetrahydrocannabinol (THC) exposure during brain development in ferrets. The research aims to examine changes in cannabinoid type-1 receptor (CB1R) expression and function, and the impact on ocular dominance plasticity (ODP) in the primary visual cortex. Key objectives include...
This Project Grant award of $220,340 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research at Washington State University to investigate the role of microglia, a type of immune cell in the brain, as a mechanism underlying the cognitive deficits associated with adolescent cannabis use. The study aims to determine if microglial activation is necessary for the impairments in cognitive flexibility observed in adulthood...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $621,186 Project Grant to the University of Wisconsin - Milwaukee (UWM). This 5-year grant, effective July 1, 2025, will fund a longitudinal study examining the impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in 2,000 youth enrolled in the Adolescent Brain Cognitive Development (ABCD) study. The research aims to...
This federal Project Grant award of $360,100 was provided by the National Institute on Drug Abuse (NIDA), which administers the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a research project titled "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project will investigate the factors influencing the use of cannabis and derived psychoactive cannabis products, such as delta-8...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $229,500 to Washington State University (WSU) from August 1, 2024 to July 31, 2026. The grant will fund research to study the mood, cognitive, and metabolic consequences of chronic vaporized cannabis exposure in mouse models of menopause. Specifically, the project will establish the pharmacokinetics of vaporized cannabis in young adult and aged...
This federal Project Grant award, ID R01DA059527, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,118,992 grant will fund a prospective investigation into the effects of cannabis use on reward and pain neurocircuits in adolescents with depression. The research aims to understand the relationships between cannabis use and depression in adolescence, which may inform prevention and intervention strategies for...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support research to explore the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders. The $314,225 award, effective July 31, 2024 through February 28, 2025, will fund a study conducted by the University of Washington to: 1) Define the behavioral profile of dual opioid-methamphetamine use disorders in a...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health outcomes. The $234,000 award, with a performance period from August 2024 to July 2026, will support a study using a well-characterized observational cohort in Colorado to measure the levels of delta-9-tetrahydrocannabinol (D9-THC) and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will provide $350,000 to Creighton University to investigate the effects of environmental enrichment on the abuse liability of minor cannabinoids such as delta-8-THC and CBD. The research aims to determine if adolescent exposure to high- or low-novelty environments can alter sensitivity to these cannabis compounds using animal models....